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TO THE EDITOR
Granulocytic sarcoma (GS), also known as chloroma, are extramedullary tumors composed of immature myeloid cells. They have been described in a wide variety of anatomical sites, including breast, ovary, brain, gastrointestinal tract and skull. 1, 2 They occur at the onset of acute myelogenous leukemia (AML) or during its evolution. They may also be the first sign of acute transformation of myelodysplastic syndromes and chronic myeloproliferative disorders. They are rarely the first manifestation of AML. GS are observed in only 2 to 8% of AML, mainly of M2 morphology, although they have also been associated with M3, M4, M5, and M7 morphology.
A 37-year-old man was referred to our hospital in June 1999. He had a history of ascitis and intestinal occlusion due to three stenotic lesions of the jejunum. A large peritoneal mass was noted. The patient had surgery in March 1999 during which a partial resection of the proximal jejunum was performed. The histologic examination of the surgical piece was interpreted as a massive lymphomatous infiltration of the whole intestine wall. In May 1999, he had surgery again because of necrosis of the tumor with cutaneous fistula. A bone marrow biopsy and a complete blood count were normal. The patient received two courses of anti-lymphoma chemotherapy.
Because of the lack of response, he was admitted to the hematology service. The patient had ileus, ascitis, severe deterioration of his health status and a 13 kg weight loss. A blood count showed a hemoglobin of 10.5 g/dl, a white blood cell (WBC) count of 4.4 × 10 9 /l and a platelet count of 343 × 10 9 /l. The leukocyte differential showed 84% neutrophils, 15% lymphocytes and 1% monocytes.
A review of the original histology found the malignant cells to be blasts. These cells were shown to contain myeloperoxidase and to express CD34 and CD68 antigens. Furthermore, immunophenotyping was partially positive for CD15 and lysozyme. A retrospective diagnosis of isolated granulocytic sarcoma was made. Unfortunately, no material was available for cytogenetic studies.
The bone marrow aspirate and the blood cell count were still normal. At the end of July 1999, chemotherapy with aracytidine and idarubicin was started, leading to the disappearance of all abdominal signs and a complete remission. No complementary radiotherapy was performed because of the small bowel localization of the granulocytic sarcoma. Then, the patient received a consolidation therapy with high Hematopoietic reconstruction was incomplete, without any signs of acute leukemia. The patient was hospitalized again at the end of August 2000 because of the presence of 39% circulating blasts. A bone marrow aspirate showed hypercellularity with 72% myeloblasts, some containing Auer rods and showing discrete abnormal granular maturation, leading to the diagnosis of AML type 2. The blasts were positive for CD13, CD34, CD117, and myeloperoxidase, but negative for lysozyme, CD35, and CD15.
A second complete remission was obtained after an induction course consisting of aracytidine and idarubicin followed, at day 15, by high-dose aracytidine and amsacrine because of the persistence of 15% blasts in the bone marrow. The abdomen remained normal. In April 2001, the patient received an allogenic bone marrow transplantation from an HLA-identical familial donor after conditioning using total body radiation (12 Gy) and cyclophosphamide (120 mg/kg). Hematopoietic reconstruction was complete but the patient presented an early acute intestinal graft-versus-host disease requiring immunosuppressive therapy. Complete hematopoietic chimerism was confirmed by cytogenetic analysis. The patient remained in complete remission until December 2001, at which time he developed a meningeal relapse of AML without medullary involvement.
Cytogenetic analysis of the patient's bone marrow cells was performed at the time of diagnosis of AML type 2. The chromosomes were R-banded. We analyzed 25 metaphases: three were 46,XY, one 47,XY,+9, inv(16)(p13q22), 19 48,XY,+9, inv(16)(p13q22), +22 and (Figure 1 ) two 49,XYY,+9, inv(16)(p13q22), +22. The FISH study using partial chromosome paint 16p (pcp(16p) Oncor, Illkirch, France) confirmed the presence of the inv(16) in all the metaphases with trisomy 22 and/or trisomy 9.
The patient reported here is one of the rare cases in which granulocytic sarcoma preceded the onset of overt acute myelogenous leukemia. [2] [3] [4] In their analysis of the effect of early antileukemic therapy in isolated chloroma, Imrie et al 5 found 83 published cases and added seven of their own. 4 They showed that chemotherapy given at diagnosis of GS delayed the onset of AML (median: 36 months vs 6 months for non-chemotherapy) and was associated with a better survival. More than half of the patients were still alive with a median followup of 25 months, compared to a median survival of 13 months for those who did not receive chemotherapy. The interval between diagnosis of GS and diagnosis of AML was 17 months in our patient, who is still alive 30 months after GS was diagnosed.
The best results were obtained when anti-AML chemotherapy was started at the diagnosis of GS. Unfortunately, in many cases, the cell morphology resembles large cell lymphoma, which may lead to mis-
Figure 1
R-banded karyotype showing the paracentric inversion of chromosome 16 and double trisomies 9 and 22. diagnosis, as the bone marrow is not involved. 3, 4 Our patient had a diagnosis of lymphoma before recognizing that it was a GS.
Cytogenetic analysis of AML patients with chloroma have rarely been reported in the literature. However, it appears that patients with t(8;21)-associated AML type 2 are more prone than others to develop GS. Indeed, 4.5 to 38% of patients with t(8;21)(q22;q22) developed GS. 1, 5 Several patients with AML type 4 in conjunction with GS and abnormalities of chromosome 16, mainly inv(16)(p13;q22) have also been reported. 3, [6] [7] [8] However, isolated granulocytic sarcoma of the small intestine preceding AML is rare; only two patients had a cytogenetic analysis using banding techniques. Le Beau et al Our patient has several features in common with the latter case (inv(16) and double trisomies 9 and 22), but for the absence of eosinophilia and the type of AML which is definitely of the FAB type 2; however, the blasts composing the granulocytic sarcoma had some monocytic characteristics which were not found in the marrow at the diagnosis of the AML. Therefore, to the best of our knowledge, this is the first report of a case of GS preceding AML type 2 with inv(16). 
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